Status
Conditions
Treatments
About
Dry eye disease (DED) is a growing public health concern affecting quality of life and visual function, with a significant socio-economic impact. It is more prevalent in the females and is being specifically in the menopausal and postmenopausal age group.
Bioptron light therapy is efficient in the elimination of allergic reactions, signs and symptoms of dry eye improving capillary circulation, immunity stimulation, relieving pain and establishing balance of tissue electromagnetic field
Full description
Around 60 postmenopausal women will be randomly divided into two equal groups, they all complain from dry eye symptoms, ranging from mild/normal to moderate and severe.
Group(A): will receive patient education program for four weeks. Group(B): will receive patient education program and bioptron light therapy for four weeks
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
• Injuries and previous surgical treatment of eyes
Primary purpose
Allocation
Interventional model
Masking
60 participants in 2 patient groups
Loading...
Central trial contact
Amel Yousef, Professor; Sara Ahmed, lecturer
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal